Literature DB >> 6166077

Myocardial "equilibration processes" and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution - reasons for a sufficiently long cardioplegic perfusion.

C J Preusse, M M Gebhard, H J Bretschneider.   

Abstract

In canine hearts the myocardial equilibration processes (temperature, pO2, pCO2, Na+, K+) and the myocardial energy turnover were analyzed at the beginning of a cardioplegically induced cardiac arrest during a coronary perfusion of 10 minutes. The investigated hearts (n = 10) were perfused with the Bretschneider histidine-buffered cardioplegic solution according to the recommendations worked out for clinical use. The results show that during the cardioplegic coronary perfusion of 10 minutes the cooling and temperature equilibration of the myocardium occur considerably faster than the establishment of a new energy steady-state at a very low level. The minimalization of the coronary resistance and of the myocardial O2 consumption are only reached after an extended perfusion period of 7 to 9 minutes. In consequence of the results, the following recommendations can be given for the clinical use of the Bretschneider cardioplegic solution: a) the solution should be used at a temperature of between 5 degrees and 10 degrees C, b) the cardioplegic coronary flow should be between 60 and 80 ml/min . 100 gww, c) the human heart should be perfused for 8 to 10 minutes and, d) the perfusion pressure should be maintained at 40 to 50 mmHg after cardiac arrest has set in. So far the action of equilibration procedures when using the Bretschneider cardioplegic method has not been compared with that of other cardioplegic methods.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166077     DOI: 10.1055/s-2007-1023446

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  10 in total

1.  The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia.

Authors:  A Schmiedl; P A Schnabel; G Mall; M M Gebhard; D H Hunneman; J Richter; H J Bretschneider
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  [Kidney protection].

Authors:  H J Bretschneider; U Helmchen; G Kehrer
Journal:  Klin Wochenschr       Date:  1988-09-15

3.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

4.  Intracellular sodium activity and Bretschneider's cardioplegia: continuous measurement by ion-selective microelectrodes at initial equilibration.

Authors:  B Stinner; E Krohn; M M Gebhard; H J Bretschneider
Journal:  Basic Res Cardiol       Date:  1989 Mar-Apr       Impact factor: 17.165

5.  Short-term perfusion and "equilibration" of canine kidneys with protective solutions.

Authors:  M Kallerhoff; M Blech; G Kehrer; H Kleinert; M Langheinrich; W Siekmann; U Helmchen; H J Bretschneider
Journal:  Urol Res       Date:  1987

6.  The cardioplegic solution HTK: effects on membrane potential, intracellular K+ and Na+ activities in sheep cardiac Purkinje fibres.

Authors:  E Krohn; B Stinner; M Fleckenstein; M M Gebhard; H J Bretschneider
Journal:  Pflugers Arch       Date:  1989-12       Impact factor: 3.657

7.  Hydroxyethyl starch does not improve pancreas preservation with HTK.

Authors:  A Tytko; B Exner; E Schrock; M Barthel; E G Siegel; H Köhler; K Nebendahl; U Leonhardt
Journal:  Langenbecks Arch Chir       Date:  1993

8.  Interstitial pH value in the myocardium as indicator of ischemic stress of cardioplegically arrested hearts.

Authors:  C J Preusse; M M Gebhard; H J Bretschneider
Journal:  Basic Res Cardiol       Date:  1982 Jul-Aug       Impact factor: 17.165

9.  Cryopreservation of Endothelial Cells in Various Cryoprotective Agents and Media - Vitrification versus Slow Freezing Methods.

Authors:  Achim von Bomhard; Alexander Elsässer; Lucas Maximilian Ritschl; Silke Schwarz; Nicole Rotter
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

10.  Effect of esmolol on myocardial protection in pediatrics congenital heart defects.

Authors:  Saeed Fazelifar; Hamid Bigdelian
Journal:  Adv Biomed Res       Date:  2015-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.